Study of NBMI Treatment in Patients With Atypical Parkinsons (PSP or MSA)

NCT04184063 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Progressive Supranuclear Palsy
Multiple System Atrophy

Interventions

DRUG: NBMI
OTHER: Placebo

Sponsor

EmeraMed